BI 655075
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 655075, covering 2016-02-15 to 2016-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran Etexilate [Phase 1]